Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S324–S335. doi: 10.1016/j.jaci.2009.11.014

TABLE I.

Immunosuppresion regimens

Immunosuppression regimen Immunological Target Specific use Major adverse effects
Radiation, anti-metabolite agents Hematopoietic Stem cells, Leukocytes BMT Cytopenias, opportunistic infections, diarrhea, alopecia, veno-occlusive disease, long-term organ damage: endocrine abnormalities, growth delay, hypodontia, cognitive delay, sterility
Calcineurin inhibitors, anti-lymphocyte antibodies, anti-cytokine antibodies, anti-metabolite agents and corticosteroids Lymphocytes In solid organ and BMT: prevention and treatment of graft rejection and of GVHD Opportunistic infections, lymphopenia, renal dysfunction, seizures, hypertrichosis, hypertension, gastritis, osteoporosis, cataracts, growth delay